Status | Study |
Recruiting |
Study Name: Sinusoidal Obstruction Syndrome for Stem Cell Transplant Patients Biomarker Study Condition: Sinusoidal Obstruction Syndrome Date: 2017-04-24 Interventions: Other: Serial Blood Draws Day 0 and Day 3 blood draw for SOS biomarkers. If subject develops SOS blood d |
Recruiting |
Study Name: European VOD Registry Condition: Hepatic Veno-Occlusive Disease Date: 2017-01-24 |
Recruiting |
Study Name: Study Comparing Efficacy and Safety of Defibrotide vs Best Supportive Care in the Prevention of Hepatic Veno-Occlusive Disease in Adult and Pediatric Patients Condition: Veno-occlusive Disease Date: 2016-07-27 Interventions: Drug: Defibrotide Other: Best Supportive C |
Not yet recruiting |
Study Name: Using Ultrasound Elastography to Predict Development of SOS Condition: Sinusoidal Obstruction Syndrome Complications of Bone Marrow Tr Date: 2015-06-25 Interventions: Procedure: shear wave ultrasound elastography |
Active, not recruiting |
Study Name: Antithrombin-III for Patients With Hepatic Veno-occlusive Diseases Following Hematopoietic Stem Cell Transplantation Condition: Hepatic Veno-Occlusive Disease Date: 2013-05-30 Interventions: Drug: Freeze-dried Concentrated Human Antithrombin Ⅲ 500 IU Other Name: Antithrombin-III Human 500 |
Completed |
Study Name: Prevention of the Hepatic Sinusoidal Obstruction Syndrome by Means of Anticoagulants Condition: Sinusoidal Obstruction Syndrome Colorectal Liver Metastases Date: 2009-04-21 |
Completed |
Study Name: Defibrotide for Patients With Hepatic Veno-occlusive Disease: A Treatment IND Study Condition: Hepatic Veno-Occlusive Disease Date: 2008-02-25 Interventions: Drug: Defibrotide |
No longer available |
Study Name: Effects on Glutamine on the Outcome of Allogeneic Bone Marrow Transplant Recipients Condition: Pulmonary Veno-Occlusive Disease Hepatic Veno-Occlusive Disease Date: 2007-11-21 Interventions: Drug: Glutamine |
Completed |
Study Name: Defibrotide for the Treatment of Severe Hepatic Veno-Occlusive Disease in Hematopoetic Stem Cell Transplant Patients Condition: Severe Hepatic Veno-Occlusive Disease Date: 2006-07-28 Interventions: Drug: Defibrotide Defibrotide 6.25 mg/kg i.v. administered four times a day via 2 hour continuous infusi |
Completed |
Study Name: Pediatric Trial Investigating the Incidence & Outcome of Veno-Occlusive Disease With the Prophylactic Use of Defibrotide Condition: Hepatic Veno-Occlusive Disease Date: 2006-01-04 Interventions: Drug: Defibrotide Defibrotide |